Skip to content
  • Русский
  • Українська
smart-pharma.group
smart-pharma.group
pharmaceutical consulting services
  • Home
  • Services
  • About Us
  • Pharmacovigilance
    • Report AE
  • Blog
  • Contact Us

Blog

Blog

  • Medicines Agencies schedule in the CIS countries due to COVID-19 pandemic

    31/03/2020
    Medicines Agencies schedule in the CIS countries due to COVID-19 pandemic

    Please, note the changes in the schedule of some Expert Centres: Ukraine – State Expert Centre of the Ministry of…


  • Basic documents in the framework of PV in the EAEU. Practical peculiarities of PSUR preparation

    27/03/2020
    Basic documents in the framework of PV in the EAEU. Practical peculiarities of PSUR preparation

    Given the evolving situation with coronavirus (COVID-19), SmartPharma Group is forced to postpone the training сourse, сonsisting of 3 webinars…


  • New Chairman of the EAEU Pharmacopoeia Committee

    27/03/2020
    New Chairman of the EAEU Pharmacopoeia Committee

    Ardak Tulegenova, a new Chairman of the EAEU Pharmacopoeia Committee who was elected on March 18, 2020, announced the release…


  • Basic documents in the framework of pharmacovigilance in the EAEU. Practical peculiarities of PSUR preparation

    10/03/2020
    Basic documents in the framework of pharmacovigilance in the EAEU. Practical peculiarities of PSUR preparation

    SmartPharma Group is delighted to invite you to participate  in a training сourse, сonsisting of 3 webinars and training workshop devoted…


  • National Centre for Expertise of Medicines and Medical Devices of the Republic of Kazakhstan has indefinitely suspended production and quality assurance inspections from February 27, 2020.

    04/03/2020
    National Centre for Expertise of Medicines and Medical Devices of the Republic of Kazakhstan has indefinitely suspended production and quality assurance inspections from February 27, 2020.

    The decision was made considering current situation with the spread of coronavirus in the world and will obviously impact marketing…


  • An audit of pharmacovigilance in health facilities will cause increased reports of adverse reactions.

    02/03/2020
    An audit of pharmacovigilance in health facilities will cause increased reports of adverse reactions.

    Roszdravnadzor sent letters  to medical organizations about the organization of pharmacovigilance work, including criteria for auditing the pharmacovigilance system. These…


  • In July 2020, new ICH guidelines should come into force

    02/03/2020
    In July 2020, new ICH guidelines should come into force

    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted 2 annexes to the guidelines…


  • Training event “Management and operation of pharmacovigilance system in EAEU

    24/02/2020
    Training event “Management and operation of pharmacovigilance system in EAEU

    Training event “Management and operation of pharmacovigilance system in EAEU. Critical aspects” was held by SmartPharma Group, on the 20-21…


  • A number of permits in the sphere of MP circulation will be available in electronic form

    18/02/2020
    A number of permits in the sphere of MP circulation will be available in electronic form

    The Government of the Russian Federation has approved the plan of transition of federal executive bodies to the implementation of…


  • Criteria for assigning software to medical devices

    17/02/2020
    Criteria for assigning software to medical devices

    The Commission of the Federal State Budgetary Institution “VNIIMT” of Roszdravnadzor for issuing conclusions on requests related to the circulation…


Previous Page
1 2 3 4 5 6
Next Page

Recent Posts

  • The Russian side opposed to postpone Implementation period of the EAEU Rules of marketing authorisation 03/12/2020
  • MedSafety app launch in the Kyrgyz Republic 25/11/2020
  • Important amendments to the EAEU legislative acts 20/10/2020

Recent Comments

    Archives

    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019

    Contact Us

    [email protected]

    Head office EU:
    23 Upes St., Vilnus,
    LT-08128, Lithuania

    +37 052 060 0 94


    CIS office:
    26 Peremohy Ave,
    Kyiv, 04116, Ukraine

    +38 044 390 31 90

    Follow Us

    EAEU office:
    7 Aprelia St., 2/10, 48,
    Bishkek, 72007, Kyrgystan

    +99 655 007 7073

    • About Us
    • Services
    • Pharmacovigilance
    Copyright © 2025 smart-pharma.group